News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,511 Results
Type
Article (8021)
Company Profile (140)
Press Release (476349)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166748)
Career Advice (305)
Deals (25739)
Drug Delivery (7)
Drug Development (52883)
Employer Resources (14)
FDA (9760)
Job Trends (8574)
News (238196)
Policy (17906)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33161)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10371)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3633)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47856)
Collaboration (1240)
Commercialization (3)
Compensation (1458)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (739)
Cystic fibrosis (85)
Data (5631)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73699)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87597)
Executive appointments (700)
FDA (12374)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (913)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (950)
Grass and pollen (2)
Guidances (281)
Healthcare (9326)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12389)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (528)
Marketing (8)
MASH (118)
Medical device (8651)
Medtech (8791)
Mergers & acquisitions (14380)
Metabolic disorders (704)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1820)
NextGen: Class of 2026 (3154)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (503)
Peanut (31)
People (41233)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15463)
Phase 2 (21372)
Phase 3 (14395)
Pipeline (7265)
Policy (18)
Postmarket research (1572)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3021)
Recruiting (6)
Regulatory (14810)
Reports (21)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (154)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (50)
Vaccines (318)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (41)
Last 7 days (398)
Last 30 days (1645)
Last 365 days (19072)
2026 (12143)
2025 (19251)
2024 (22988)
2023 (26540)
2022 (34588)
2021 (37176)
2020 (33481)
2019 (23256)
2018 (17469)
2017 (18765)
2016 (17920)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17884)
Australia (2097)
California (11923)
Canada (3130)
China (519)
Colorado (482)
Connecticut (408)
Delaware (208)
Europe (24625)
Florida (1784)
Georgia (376)
Hawaii (3)
Idaho (46)
Illinois (696)
India (49)
Indiana (314)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1199)
Massachusetts (7836)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2615)
New Mexico (12)
New York (2815)
North Carolina (1269)
North Dakota (4)
Northern California (5969)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2246)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4951)
Tennessee (119)
Texas (1930)
United States (38741)
Utah (358)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (924)
West Virginia (1)
Wisconsin (73)
484,511 Results for "genprex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
August 3, 2026
·
7 min read
Press Releases
Genprex to Participate at BIO International Convention 2026
June 17, 2026
·
5 min read
Press Releases
Genprex to Participate at BIO Europe Spring 2026
March 10, 2026
·
5 min read
Press Releases
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
April 21, 2026
·
9 min read
Press Releases
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
June 22, 2026
·
7 min read
Press Releases
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
April 30, 2026
·
6 min read
Press Releases
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
January 7, 2026
·
8 min read
Press Releases
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
May 14, 2026
·
7 min read
Press Releases
Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
April 28, 2026
·
8 min read
Press Releases
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
April 20, 2026
·
12 min read
1 of 48,452
Next
